secwatch.observer — SEC 8-K summary
======================================

Issuer:     LAM RESEARCH CORP (LRCX)
CIK:        0000707549
Form:       8-K
Filed at:   2023-08-24T23:59:59+00:00
Accession:  0000707549-23-000105
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lam Research appoints former GE Healthcare CEO John M. Dineen to board
----------------------------------------------------------------------

- Board expanded to 11 members with Dineen's appointment effective August 24, 2023.
- Dineen will join the Audit Committee effective November 7, 2023.
- He served as President and CEO of GE Healthcare and held senior roles at GE over 30 years.
- Dineen currently serves on boards of Cognizant, Syneos Health, Healogics, and Carestream Dental.
- He will receive standard non-employee director compensation and enter a standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/707549/000070754923000105/0000707549-23-000105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/707549/000070754923000105/lrcx-20230823.htm
  HTML page:      https://secwatch.observer/filing/0000707549-23-000105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer